Depressive Disorders: A Modern View of the Problem

Actualization of the problem As shown by a recent study, the detection of cases of depression by general practitioners is difficult because in almost half of cases, patients try to keep silent about the symptoms of the disease ( suffering in silence ) [3]. Many are afraid of prescribing antidepressants and their side effects; some believe that…

Continue reading

Efficacy and safety of pregabalin in the treatment of neuropathic pain

According to the updated definition of the International Association for the Study of Pain (IASP), NB is a condition caused by damage or disease of the somatosensory system. Updated detection was made with the aim to differentiate NB from pain or nociceptive cent – eral origin. In addition, the updated definition indicates the need for a survey to…

Continue reading

Dossier of the drug: 60 years of experience with methylprednisolone

The effectiveness of the steroid hormones cortisone, hydrocortisone, prednisone and prednisolone in the treatment of bronchial asthma (BA), other diseases of allergic origin, rheumatoid arthritis, inflammatory bowel diseases and autoimmune pathology is beyond doubt. However, the use of these HA is limited due to their ability to cause such adverse effects as mineral imbalance, activation…

Continue reading

Antidepressant Discontinuation Syndrome: Diagnosis, Prevention and Treatment

 This condition is also called antidepressant withdrawal syndrome, although this is not entirely correct. The onset of symptoms after stopping therapy does not mean that the drug is addictive. Antidepressants are non- addictive and non- addictive. This is an important positive point that should be communicated to patients, since most people will stop taking the prescribed treatment as soon as…

Continue reading